Literature DB >> 222135

High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study.

U Goldbourt, J H Medalie.   

Abstract

Using univariate and multivariate analyses, the association between high density lipoprotein (HDL) cholesterol and coronary heart disease (CHD) incidence was investigated. Over 150 cases of myocardial infarction (MI) occurred among 6500 Israeli adult males in a five-year prospective study. At age 50 years and over, there is a significant inverse association between MI incidence and HDL cholesterol. This relationship persists when controlling for risk factors such as age, other cholesterol components, smoking, blood pressure, weight, and diabetes mellitus. Unlike hypercholesterolemia and smoking, the relative risk with HDL cholesterol increases with age above 50. Similar patterns of association occur between HDL cholesterol and angina pectoris incidence, sudden unexpected death and deaths from MI. It is suggested that HDL cholesterol is an independent risk factor for CHD, especially in males over 50, and the implication of this study is that increased HDL cholesterol might play a protective role in the pathogenesis of CHD.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222135     DOI: 10.1093/oxfordjournals.aje.a112683

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  38 in total

Review 1.  Plasma lipoproteins, lipid transport, and atherosclerosis: recent developments.

Authors:  N E Miller
Journal:  J Clin Pathol       Date:  1979-07       Impact factor: 3.411

2.  High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.

Authors:  S J Pocock; A G Shaper; A N Phillips; M Walker; T P Whitehead
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-22

3.  Serum lipids and coronary heart disease in British elderly.

Authors:  D M Mangion; S S Roy
Journal:  Postgrad Med J       Date:  1993-08       Impact factor: 2.401

4.  [Predictor function of hemorheologic parameters with reference to the incidence of manifest circulatory disorders: Concept of the Aachen study].

Authors:  H Kiesewetter; F Jung; K H Ladwig; E Waterloh; P Roebruck; R Schneider; G Kotitschke; R Bach
Journal:  Klin Wochenschr       Date:  1986-07-15

5.  Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study.

Authors:  A G Shaper; S J Pocock; M Walker; A N Phillips; T P Whitehead; P W Macfarlane
Journal:  J Epidemiol Community Health       Date:  1985-09       Impact factor: 3.710

6.  Lipid profile of a French-Canadian population: 1. Association of plasma lipid and lipoprotein levels with age, relative body weight and education.

Authors:  P J Lupien; S Moorjani; J Rochon; G R Dagenais; L A Fleury; J Jobin; N M Robitaille
Journal:  CMAJ       Date:  1985-12-01       Impact factor: 8.262

7.  Raising HDL cholesterol with low-dose nicotinic acid and bezafibrate: preliminary experience.

Authors:  M H Luria; D Sapoznikov
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

8.  Distribution of high-density lipoprotein cholesterol according to age, sex, and ethnic origin: cardiovascular disease study in Finnmark 1977.

Authors:  D S Thelle; O H Førde; E Arnesen
Journal:  J Epidemiol Community Health       Date:  1982-12       Impact factor: 3.710

9.  Segregation analysis of low levels of high-density lipoprotein cholesterol in the collaborative Lipid Research Clinics Program Family Study.

Authors:  K D Bucher; E B Kaplan; K K Namboodiri; C J Glueck; P Laskarzewski; B M Rifkind
Journal:  Am J Hum Genet       Date:  1987-06       Impact factor: 11.025

10.  Hypercholesterolemia in five Israeli Christian-Arab kindreds is caused by the "Lebanese" allele at the low density lipoprotein receptor gene locus and by an additional independent major factor.

Authors:  A Oppenheim; Y Friedlander; E J Dann; N Berkman; S P Schwartz; E Leitersdorf
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.